Baseline ophthalmic findings in the Vitamin E, Cataract and Age-Related Maculopathy (VECAT) study

Australian and New Zealand Journal of Ophthalmology

Volumn 27, Issue 6, 1999, Pages 410-416

  Robman, L D ^a   Tikellis, G ^b   Garrett, S K M ^b   Harper, C A ^a   McNeil, J J ^b   Taylor, H R ^a   McCarty, C A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Age related maculopathy; Cataract; Maculopathy; Randomized controlled trial

Indexed keywords

ALPHA TOCOPHEROL;

ADULT; AGED; ARTICLE; AUSTRALIA; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA OPACITY; DRUSEN; EYE PHOTOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PIGMENT EPITHELIUM; PREVALENCE; PTERYGIUM; RANDOMIZED CONTROLLED TRIAL; RETINA MACULOPATHY; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; CATARACT; FEMALE; HUMANS; INCIDENCE; LENS, CRYSTALLINE; MACULAR DEGENERATION; MALE; MIDDLE AGED; PATIENT SELECTION; PHOTOGRAPHY; RETINA; URBAN POPULATION; VICTORIA; VISUAL ACUITY; VITAMIN E;

EID: 0033377501     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1606.1999.00240.x     Document Type: Article

References (15)

1. West SK. Who develops cataracts? (Editorial.) Arch. Ophthalmol. 1991; 109: 196-8.
2. Garrett SKM, Thomas AP, McNeil JJ, Taylor HR. Community based recruitment strategies for a longitudinal interventional study: the VECAT experience. Proceedings of the ARVO Meeting, 21-26 April 1996, Fort Lauderdale, Florida. Invest. Ophthalmol. Vis. Sci. 1996; 37: S306.
3. Seddon JM, Sahagian CR, Glynn RJ, Sperduto RD, Gragoudas ES. Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1592-8.
4. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am. J. Optom. Physiol. Opt. 1974; 53: 740-45.
5. Taylor HR, West SK. A simple system for the clinical grading of lens opacities. Lens Res. 1988; 5: 175-81.
6. Taylor HR, West SK. The clinical grading of lens opacities. Aust. N.Z. J. Ophthalmol. 1989; 17: 81-6.
7. Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effect of scaling. Invest. Ophthalmol. Vis. Sci. 1991; 32: 422-32.
8. Livingston PM, Carson CA, Stanislavsky YL, Lee SE, Guest CS, Taylor HR. Methods for a population-based study of eye disease: The Melbourne Visual Impairment Project. Ophthalmic Epidemiol. 1994; 1: 139-48.
9. Anon. Anterior eye segment analysis system: EAS-1000. Operator's manual. Tokyo: Nidek Co. Ltd, 1991.
10. Robman LD, McCarty CA, Garrett SKM, Stephenson H, Thomas AP, McNeil JJ, Taylor HR. Comparison of clinical and Nidek EAS-1000 assessment of nuclear opacity. Ophthalmic Res. 1999; 31: 119-26.
11. Robman L, McCarty CA, Garrett SKM, Maclean H, McNeil JJ, Taylor HR. Variability in the assessment of cortical cataract with the Nidek EAS-1000. Ophthalmic Res. 1999; 31: 110-18.
12. Bird AC, Bressler NM, Bressler SB et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 1995; 39: 367-74.
13. Duke-Elder S. Diseases of the lens and vitreous. Coronary cataract. In: System of Ophthalmology, Vol. XI, 1969; 148-52.
14. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. Ophthalmology 1995; 102: 1450-60.
15. Rudnicka AR, Burk ROW, Edgar DF, Fritzke FW. Magnification characteristics of fundus imaging systems. Ophthalmology 1998; 105: 2186-92.